Top

Diabetes Therapy

Published in:

Open Access 01-08-2020 | Editorial

Diabetes Podcast: Do It Yourself/Open Source Artificial Pancreas Systems: Part 1

Authors: Sufyan Hussain, Dana Lewis

Published in: Diabetes Therapy | Issue 8/2020

Excerpt

Video: Do it Yourself/Open Source Artificial Pancreas Systems: Part 1 podcast recording (MP4 701465 kb)

…

Lewis D. Automated Insulin Delivery: how artificial pancreas “closed loop” systems can aid you in living with diabetes. 2019. https://www.amazon.com/gp/product/B07R6VJJTH/ref=as_li_tl?ie=UTF8&camp=1789&creative=9325&creativeASIN=B07R6VJJTH&linkCode=as2&tag=diyps-20&linkId=943eac0db2580e0a6a21af4cb15c8d99. Accessed Nov 2019.

Lewis D. History and perspective on DIY closed looping. J Diabetes Sci Technol. 2019;13(4):790–3.CrossRef

The King's Fund. Shared responsibility for health: the cultural change we need. 2018. https://www.kingsfund.org.uk/publications/shared-responsibility-health. Accessed Nov 2019.

Nesta. The NHS in 2030: a vision of a people-powered, knowledge-powered health system. 2015. https://media.nesta.org.uk/documents/the-nhs-in-2030.pdf. Accessed Nov 2019.

Lewis DM. How APS works. Automated insulin delivery: how artificial pancreas “closed loop” systems can aid you in living with diabetes. 2019. https://www.artificialpancreasbook.com/1.-whats-a-closed-loop-or-artificial-pancreas-system-and-why-would-someone-use-one#how-aps-works. Accessed Nov 2019.

Foster NC, Beck R, Miller K, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72.CrossRef

Lewis D. Setting expectations for successful artificial pancreas/hybrid closed loop/automated insulin delivery adoption. J Diabetes Sci Technol. 2018;12(2):533–4.CrossRef

Marshall DC, et al. Do-it-yourself artificial pancreas systems in type 1 diabetes: perspectives of two adult users, a caregiver and three physicians. Diabetes Ther. 2019;10(5):1553–64. https://doi.org/10.1007/s13300-019-00679-y.CrossRefPubMedPubMedCentral

Jennings P, et al. Do-it-yourself artificial pancreas systems: a review of the emerging evidence and insights for healthcare professionals. J Diabetes Sci Technol. 2019. https://doi.org/10.1177/1932296819894296.CrossRefPubMed

10.

Lewis D, Leibrand S. Real-world use of open source artificial pancreas systems. J Diabetes Sci Technol. 2016;10(6):1411.CrossRef

11.

Lewis DM, Swain RS, Donner TW. Improvements in A1C and time-in-range in DIY closed-loop (OpenAPS) users. Diabetes. 2018. https://doi.org/10.2337/db18-352-OR.CrossRefPubMedPubMedCentral

12.

Melmer A, Züger T, Lewis DM, Leibrand S, Stettler C, Laimer M. Glycemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS). Diabetes Obes Metab. 2019;21(10):2333–7. https://doi.org/10.1111/dom.13810.

13.

Lee JM, Newman MW, Gebremariam A, et al. Real-world use and self-reported health outcomes of a patient-designed do-it-yourself mobile technology system for diabetes: lessons for mobile health. Diabetes Technol Ther. 2017;19:209–19. https://doi.org/10.1089/dia.2016.0312.CrossRefPubMed

14.

Braune K, O’Donnell S, Cleal B, Lewis D, Tappe A, Willaing I, et al. Real-world use of do-it-yourself artificial pancreas systems in children and adolescents with type 1 diabetes: online survey and analysis of self-reported clinical outcomes. JMIR MHealth UHealth. 2019;7:e14087. https://doi.org/10.2196/14087.CrossRefPubMedPubMedCentral

15.

Provenzano V, Guastamacchia E, Brancato D, et al. Closing the loop with OpenAPS in people with type 1 diabetes—experience from Italy. Diabetes. 2018;67(Suppl 1). https://doi.org/10.2337/db18-993-P.

16.

Choi SB, Hong ES, Noh YH. Open artificial pancreas system reduced hypoglycemia and improved glycemic control in patients with type 1 diabetes. Diabetes. 2018;67(Suppl 1). https://doi.org/10.2337/db18-964-P.

17.

Petruzelkova L, Soupal J, Plasova V, et al. Excellent glycemic control maintained by open-source hybrid closed-loop AndroidAPS during and after sustained physical activity. Diabetes Technol Ther. 2018;20(11):744–50. https://doi.org/10.1089/dia.2018.0214.

18.

Koutsovasilis et al. Clinical evaluation of a closed-loop insulin delivery system on glycaemic control in adults with type 1 diabetes. In: European Association for the Study of Diabetes (EASD) virtual meeting. 2019. https://www.easd.org/virtualmeeting/home.html#!resources/clinical-evaluation-of-a-closed-loop-insulin-delivery-system-on-glycaemic-control-in-adults-with-type-1-diabetes-134c4ad2-53f1-4698-927f-5bd287a76a5d.

19.

University of Otago. The CREATE Trial. 2019. https://www.otago.ac.nz/christchurch/departments/paediatrics/research/otago717634.html. Accessed Nov 2019.

20.

Melmer A, Züger T, Lewis D, Leibrand S, Stettler C, Laimer M. Glycemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS). Diabetes Obes Metab. 2019;21(10):2333–7. https://doi.org/10.1111/dom.13810.

21.

Toffanin C, et al. In silico trials of an open-source android-based artificial pancreas: a new paradigm to test safety and efficacy of do-it-yourself systems. Diabetes Technol Ther. 2019. https://doi.org/10.1089/dia.2019.0375.CrossRefPubMed

22.

The Open Project. DIWHY n.d. 2019. https://open-diabetes.eu/research/diwhy/. Accessed 18 Oct 2019.

23.

Braune K, O’Donnell S, Cleal B, et al. Real-world use of do-it-yourself artificial pancreas systems in children and adolescents: self-reported clinical outcomes. JMIR mHealth UHealth. 2019;7(7):e14087. https://doi.org/10.2196/14087.CrossRefPubMedPubMedCentral

24.

OpenAPS.Org. OpenAPS Data commons. 2019. https://openaps.org/data-commons/. Accessed 22 Aug 2019.

Title: Diabetes Podcast: Do It Yourself/Open Source Artificial Pancreas Systems: Part 1
Authors: Sufyan Hussain
Dana Lewis
Publication date: 01-08-2020
Publisher: Springer Healthcare
Published in: Diabetes Therapy / Issue 8/2020
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI: https://doi.org/10.1007/s13300-020-00827-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2020

Why Do Falls and Lower Limb Fractures Occur More Frequently in the Diabetic Patient and How Can They Be Prevented?

Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study

Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes

Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden

Key Strategies for Overcoming Psychological Insulin Resistance in Adults with Type 2 Diabetes: The UK Subgroup in the EMOTION Study

Glycemic Control and its Predictors among Adult Diabetic Patients attending Mettu Karl Referral Hospital, Southwest Ethiopia: A Prospective Observational Study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials